Delivery Order SPE2DB20D1100-SPE2DB22FC3T3

Award Date 7/6/22
Potential Completion Date 7/27/22
Potential Value $79K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,251.17 contract is for the supply of OPDIVO 40 MG/4 ML VIAL 4ML, a specialty medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $38,237.00. The order is for the supply of 240 mg/24 mL vials of the cancer medication OPDIVO. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,689.30, is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract is a firm fixed-price delivery order, with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,937.86 firm fixed-price delivery order is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of OPDIVO 240 MG/24 ML VIAL 24ML pharmaceutical products. The contract has a ceiling value of $38,237.00 and a period of performance through April 26, 2024. This delivery order is placed under a larger $999,999,999.00 indefinite delivery contract (IDC) that serves as the primary vehicle for AmerisourceBergen to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,371.90, is for the procurement of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 12, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a prescription medication, at a fixed price of $38,237.00. The ultimate completion date for this delivery order is September 24, 2024. This contract is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,937.86, is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product. The contract has a period of performance through February 11, 2025 and utilizes a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $15,294.80. The order is for 4,565,628,285 units of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The order has an ultimate completion date of September 20, 2024 and was awarded on August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPDIVO 100 MG/10 ML VIAL 10ML, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $6,193.26 and runs through April 18, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB22FC3T3
    Delivery Order

This is a $78,951.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty cancer medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/2/25, 6:27 PM